|
Volumn 356, Issue 9228, 2000, Pages 509-510
|
First-line antihypertensive therapy.
a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR;
ANTIHYPERTENSIVE AGENT;
CHLORTALIDONE;
DOXAZOSIN;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
CONTROLLED CLINICAL TRIAL;
CYTOLOGY;
HEART MUSCLE;
HUMAN;
NOTE;
PHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
ANTIHYPERTENSIVE AGENTS;
CHLORTHALIDONE;
DOXAZOSIN;
HEART FAILURE, CONGESTIVE;
HUMANS;
MYOCARDIUM;
RANDOMIZED CONTROLLED TRIALS;
RECEPTORS, ADRENERGIC, ALPHA;
|
EID: 0034609080
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)74182-9 Document Type: Letter |
Times cited : (8)
|
References (0)
|